文献速递脑血管病

缺血核心体积与取栓或溶栓后临床结局的关系

Exploring the relationship between ischemic core volume and clinical outcomes after thrombectomy or thrombolysis.
PubMed 文献 · Neurology · 2019-06-17

该研究将INSPIRE注册中141例EVT后完全再灌注患者与141例按年龄、临床严重度、闭塞部位及基线灌注病灶体积匹配的IVT后完全再灌注患者比较,按基线缺血核心与半暗带体积五分位分析90天mRS 0-1的结局。核心<30 mL者EVT-R结局劣于IVT-R,核心>30 mL者EVT-R结局更优且IVT-R症状性颅内出血更多。

要点

  • 基线核心<30 mL且多为远端M1/M2闭塞、侧支良好者,EVT-R的90天良好结局几率低于IVT-R。
  • 基线核心>30 mL且多为颈内动脉或近端M1闭塞者,EVT-R的90天良好结局几率高于IVT-R。
  • 核心>30 mL时IVT-R组症状性颅内出血发生率高于EVT-R组。

核心结论

  • 大核心、近端LVO且侧支较差者,EVT-R较单纯IVT-R明确获益;远端LVO、小核心且侧支良好者,EVT-R与良好结局几率降低相关。

研究设计与样本

  • 观察性队列研究,EVT-R患者按年龄、临床严重度、闭塞部位和基线灌注病灶体积与INSPIRE中IVT-R患者匹配。
  • 共纳入141例EVT-R患者和141例匹配的IVT-R对照,仅纳入随访影像显示完全再灌注者。
  • 按基线缺血核心和半暗带体积五分位比较EVT-R与IVT-R的90天mRS 0-1结局。

主要发现

  • 基线核心<30 mL者,EVT-R的90天mRS 0-1比值比为0.01(p<0.001)。
  • 基线核心<30 mL组多为远端M1或M2闭塞且侧支良好(p=0.01)。
  • 基线核心>30 mL者,EVT-R的90天mRS 0-1比值比为1.61(p<0.001)。
  • 核心>30 mL时IVT-R组症状性颅内出血为20%,EVT-R组为3%(p=0.008)。

关键数值与推荐

  • 90天良好临床结局定义为mRS 0-1。
  • 基线缺血核心以30 mL为界分层分析。
  • 核心<30 mL:EVT-R的90天mRS 0-1 OR 0.01,p<0.001。
  • 核心>30 mL:EVT-R的90天mRS 0-1 OR 1.61,p<0.001;症状性颅内出血IVT-R 20% vs EVT-R 3%,p=0.008。

临床怎么用

  • 对近端LVO、大缺血核心且侧支较差者,完全再灌注的EVT策略结局优于单纯IVT再灌注。
  • 对远端LVO、小核心且侧支良好者,需权衡EVT-R与IVT-R的结局差异。
  • 核心>30 mL时IVT-R的症状性颅内出血风险更高,选择再灌注策略时应予考虑。

局限性

  • 为观察性队列研究,EVT-R与IVT-R的比较基于匹配而非随机化。
  • 仅纳入随访影像显示完全再灌注的患者,结论不能外推至未完全再灌注者。
  • 样本来自INSPIRE注册,EVT-R与IVT-R各141例,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess whether complete reperfusion after IV thrombolysis (IVT-R) would result in similar clinical outcomes compared to complete reperfusion after endovascular thrombectomy (EVT-R) in patients with a large vessel occlusion (LVO). METHODS: EVT-R patients were matched by age, clinical severity, occlusion location, and baseline perfusion lesion volume to IVT-R patients from the International Stroke Perfusion Imaging Registry (INSPIRE). Only patients with complete reperfusion on follow-up imaging were included. The excellent clinical outcome rates at day 90 on the modified Rankin Scale (mRS) were compared between EVT-R vs IVT-R patients within quintiles of increasing baseline ischemic core and penumbral volumes. RESULTS: From INSPIRE, there were 141 EVT-R patients and 141 matched controls (IVT-R) who met the eligibility criteria. In patients with a baseline core <30 mL, EVT-R resulted in a lower odds of achieving an excellent outcome at day 90 compared to IVT-R (day 90 mRS 0-1 odds ratio 0.01, p < 0.001). The group with a baseline core <30 mL contained mostly patients with distal M1 or M2 occlusions, and good collaterals (p = 0.01). In patients with a baseline ischemic core volume >30 mL (internal carotid artery and mostly proximal M1 occlusions), EVT-R increased the odds of patients achieving an excellent clinical outcome (day 90 mRS 0-1 odds ratio 1.61, p < 0.001) and there was increased symptomatic intracranial hemorrhage in the IVT-R group with core >30 mL (20% vs 3% in EVT-R, p = 0.008). CONCLUSION: From this observational cohort, LVO patients with larger baseline ischemic cores and proximal LVO, with poorer collaterals, clearly benefited from EVT-R compared to IVT-R alone. However, for distal LVO patients, with smaller ischemic cores and better collaterals, EVT-R was associated with a lower odds of favorable outcome compared to IVT-R alone.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Chen C, Parsons MW, Levi CR, et al. Exploring the relationship between ischemic core volume and clinical outcomes after thrombectomy or thrombolysis. Neurology. 2019. PMID: 31209178. doi:10.1212/WNL.0000000000007768

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。